Companies:
53,124
Total Market Cap:
168037162640297.27
Global Rank
#37283
Country Rank
#2189
Market Cap
20.69 M
Price
0.476
Change (%)
14.93%
Volume
1.06 M
Vectorite Biomedical's latest marketcap:
20.69 M
As of 07/19/2026, Vectorite Biomedical's market capitalization has reached $20.69 M. According to our data, Vectorite Biomedical is the 37283th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 20.69 M |
| Revenue (ttm) | 1.9 M |
| Net Income (ttm) | 2.97 M |
| Shares Out | 43.77 M |
| EPS (ttm) | 0.07 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/11/2026 |
Market Cap Chart
Data Updated: 07/19/2026
Vectorite Biomedical's yearly market capitalization.
Vectorite Biomedical has seen its market value drop from NT$1.71 B to NT$669.7 M since 2014, representing a total decrease of 60.73% and an annual compound decline rate (CAGR) of 7.78%.
| Date | Market Cap(NT$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/19/2026 | NT$669.7 M | $20.69 M | -7.86% | 37283 |
| 12/31/2025 | NT$612.8 M | $19.52 M | -3.45% | 34940 |
| 12/31/2024 | NT$634.68 M | $19.33 M | -32.08% | 34377 |
| 12/29/2023 | NT$934.52 M | $30.4 M | 157.56% | 31081 |
| 07/23/2020 | NT$362.83 M | $12.9 M | -42.02% | 31254 |
| 12/31/2019 | NT$625.78 M | $20.89 M | -33.47% | 26223 |
| 12/28/2018 | NT$940.57 M | $30.72 M | -51.05% | 23526 |
| 12/29/2017 | NT$1.92 B | $64.65 M | 148.83% | 20237 |
| 12/30/2016 | NT$772.16 M | $23.77 M | -45.42% | 22608 |
| 12/31/2015 | NT$1.41 B | $42.9 M | -17.05% | 18882 |
Company Profile
About Vectorite Biomedical Inc.
Vectorite Biomedical Inc. is a biotechnology company specializing in research and development, with operations in Taiwan and internationally.
Core Offerings
- Cell preparation product manufacturing
- Collection, processing, and storage management of immune cells
Applications
The company's cell preparation products are utilized in key medical fields, including:
- Infectious diseases and inflammation
- Cancer and tumor diseases
Company Background
Founded in 1993, Vectorite Biomedical Inc. is headquartered in New Taipei City, Taiwan.
Frequently Asked Questions
-
What is Vectorite Biomedical's (TPEX-4170) current market cap?As of 07/19/2026, Vectorite Biomedical (including the parent company, if applicable) has an estimated market capitalization of $20.69 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Vectorite Biomedical (TPEX-4170) rank globally by market cap?Vectorite Biomedical global market capitalization ranking is approximately 37283 as of 07/19/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.